Non-confidential technology presentation

Jun. 22-26, 2007
Long acting GLP-1 for the treatment of Type 2 diabetes
No. 0540-P. Presented at the American Diabetes Association 67th Scientific Sessions, Chicago , IL.

Jun. 22-25, 2007
Long acting GLP-1: formulation and in vitro evaluation
No. 0475-P. Presented at the American Diabetes Association 67th Scientific Sessions, Chicago, IL.

Jun. 22-26, 2007
PGC GLP-1: Pharmacokinetics in rodents
No. 2185- PO . Publication only, American Diabetes Association 67th Scientific Sessions, Chicago , IL.